Docusign's recent correction creates a buy opportunity, hinging on cheap valuations and potential growth rebound from IAM product expansion. Growth concerns are valid due to slowing billings and ...

There was a lot to like about DocuSign's latest quarter. Revenue and adjusted earnings per share were up 8% and 10%, respectively, topping Wall Street expectations. GAAP (generally accepted accounting ...

DocuSign posted revenue and earnings growth, beating estimates. The company's free cash flow fell slightly, and its full-year forecast underwhelmed investors. DocuSign has steadied itself, but ...